Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-28

Clinical Trial Update: Evaluation of Whole Blood With CPD Anticoagulant and AS-7/SOLX Additive Solution [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating whole blood collection using CPD anticoagulant and AS-7/SOLX additive solution; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Haemonetics Corporation | Conditions: Blood Donors | Phase 1 | Status: COMPLETED | Results posted: 2022-03-28